My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Veru Inc. - Common Stock (NQ:VERU)

2.300 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Veru Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Veru (VERU) Q1 2026 Earnings Call Transcript ↗

February 11, 2026

Veru (VERU) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

VERU INC (NASDAQ:VERU) Reports Narrower-Than-Expected Q1 Loss, Highlights Key Clinical Trial Timeline ↗

February 11, 2026

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 30, 2025

Via Benzinga

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

October 30, 2025

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

A Look Ahead: Veru's Earnings Forecast ↗

August 11, 2025

Via Benzinga

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial ↗

May 28, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

A Peek at Veru's Future Earnings ↗

May 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 30, 2025

Via Benzinga

What's going on in today's after hours session ↗

October 29, 2025

The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 29, 2025

Via Benzinga

Eli Lilly Ends Bimagrumab Obesity Study Weeks After Launch ↗

September 25, 2025

On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began.

Via Benzinga

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

These stocks are gapping in today's session ↗

May 28, 2025

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 28, 2025

Via Benzinga

Which stocks are experiencing notable movement on Tuesday? ↗

April 01, 2025

Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

April 01, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Which stocks are experiencing notable movement on Monday? ↗

January 27, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher ↗

January 27, 2025

Via Benzinga

Topics Stocks

These stocks are moving in today's session ↗

January 27, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Dow Edges Higher; AT&T Posts Upbeat Earnings ↗

January 27, 2025

Via Benzinga

Topics Stocks

Traders are paying attention to the gapping stocks in Monday's session. ↗

January 27, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough ↗

January 27, 2025

Veru's enobosarm showed significant body composition benefits in Phase 2b trials with semaglutide. Extension study results are due in April 2025.

Via Benzinga

Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December ↗

January 27, 2025

Via Benzinga

Topics Economy

These stocks that are showing activity before the opening bell on Monday. ↗

January 27, 2025

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline ↗

December 31, 2024

Veru jumps after selling FC2 Female Condom business for $18 million, reducing workforce by 90%.

Via Benzinga

12 Consumer Staples Stocks Moving In Friday's Pre-Market Session ↗

October 11, 2024

Via Benzinga

12 Consumer Staples Stocks Moving In Thursday's After-Market Session ↗

October 10, 2024

Via Benzinga

VERU Stock Earnings: Veru Beats EPS, Misses Revenue for Q1 2024 ↗

June 26, 2024

VERU stock results show that Veru beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition